Pharmaceutical Tablet Manufacturing – Antifungal Medication

This contract involves the manufacture of Fluconazole 150 mg tablets, adhering strictly to USP standards, which encompasses sourcing the active pharmaceutical ingredient (API), formulation, tablet compression, and comprehensive quality control testing to ensure product efficacy and safety. The work is designated as a subcontract under the NAICS code 325412, which relates to pharmaceutical preparation manufacturing. The contracting agency is the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, highlighting the strategic importance and regulatory oversight associated with this pharmaceutical product intended for antifungal treatment. Performance of the contract is scheduled for Fort Bragg, zip code 28310, with the solicitation posted on May 18, 2026, and responses due by May 26, 2026, indicating a relatively brief window for proposal submission. Specific organization type and set-aside details are not provided, suggesting an open solicitation. The focus on USP compliance underscores the necessity for rigorous quality assurance and assurance of product standards in manufacturing, reflecting the critical role this medication plays in supporting military and related healthcare needs.